BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Valentino RJ, Volkow ND. Drugs, sleep, and the addicted brain. Neuropsychopharmacology 2020;45:3-5. [PMID: 31311031 DOI: 10.1038/s41386-019-0465-x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Guo R, Vaughan DT, Rojo ALA, Huang YH. Sleep-mediated regulation of reward circuits: implications in substance use disorders. Neuropsychopharmacology 2022. [PMID: 35710601 DOI: 10.1038/s41386-022-01356-8] [Reference Citation Analysis]
2 Bauer LO. Temporal instability in brain activation: a novel paradigm for evaluating the maintenance of attention among substance dependent patients. Psychopharmacology (Berl) 2021. [PMID: 34196741 DOI: 10.1007/s00213-021-05909-5] [Reference Citation Analysis]
3 Laniepce A, Lahbairi N, Cabé N, Pitel AL, Rauchs G. Contribution of sleep disturbances to the heterogeneity of cognitive and brain alterations in alcohol use disorder. Sleep Med Rev 2021;58:101435. [PMID: 33578081 DOI: 10.1016/j.smrv.2021.101435] [Reference Citation Analysis]
4 Jeremic D, Sanchez-Rodriguez I, Jimenez-Diaz L, Navarro-Lopez JD. Therapeutic potential of targeting G protein-gated inwardly rectifying potassium (GIRK) channels in the central nervous system. Pharmacol Ther 2021;223:107808. [PMID: 33476640 DOI: 10.1016/j.pharmthera.2021.107808] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
5 McGregor R, Thannickal TC, Siegel JM. Pleasure, addiction, and hypocretin (orexin). Handb Clin Neurol 2021;180:359-74. [PMID: 34225941 DOI: 10.1016/B978-0-12-820107-7.00022-7] [Reference Citation Analysis]
6 Sakai K, Ishikawa A, Mizuno Y, Maki T, Oda Y, Takahashi E. Simplified drug efficacy screening system for sleep-disorder drugs using non-human primates. Heliyon 2020;6:e03524. [PMID: 32154428 DOI: 10.1016/j.heliyon.2020.e03524] [Reference Citation Analysis]
7 Vrajová M, Šlamberová R, Hoschl C, Ovsepian SV. Methamphetamine and sleep impairments: neurobehavioral correlates and molecular mechanisms. Sleep 2021;44:zsab001. [PMID: 33406259 DOI: 10.1093/sleep/zsab001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Raymond JS, Rehn S, Hoyos CM, Bowen MT. The influence of oxytocin-based interventions on sleep-wake and sleep-related behaviour and neurobiology: A systematic review of preclinical and clinical studies. Neurosci Biobehav Rev 2021;131:1005-26. [PMID: 34673110 DOI: 10.1016/j.neubiorev.2021.10.016] [Reference Citation Analysis]
9 Liang F, Xu Q, Jiang M, Feng R, Jiang S, Yuan B, Xu S, Wu T, Wang F, Huang JH. Emotion Induced Monoamine Neuromodulator Release Affects Functional Neurological Disorders. Front Cell Dev Biol 2021;9:633048. [PMID: 33659255 DOI: 10.3389/fcell.2021.633048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Luca G, Peris L. Sleep Quality and Sleep Disturbance Perception in Dual Disorder Patients. J Clin Med 2020;9:E2015. [PMID: 32604951 DOI: 10.3390/jcm9062015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
11 Jenkins DD, Khodaparast N, O'Leary GH, Washburn SN, Covalin A, Badran BW. Transcutaneous Auricular Neurostimulation (tAN): A Novel Adjuvant Treatment in Neonatal Opioid Withdrawal Syndrome. Front Hum Neurosci 2021;15:648556. [PMID: 33762918 DOI: 10.3389/fnhum.2021.648556] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Berro LF, Roehrs T. Catching up on sleep: Recent evidence on the role of sleep in substance use disorders. Pharmacol Biochem Behav 2022;213:173330. [PMID: 34995638 DOI: 10.1016/j.pbb.2022.173330] [Reference Citation Analysis]
13 McGee-Vincent P, Juhasz K, Jamison AL, Avery TJ, Owen JE, Jaworski BK, Blonigen DM. Mobile Mental Health Apps from the National Center for PTSD: Digital Self-Management Tools for Co-Occurring Disorders. J Dual Diagn 2021;:1-12. [PMID: 34152258 DOI: 10.1080/15504263.2021.1939919] [Reference Citation Analysis]
14 Greenwald MK, Moses TEH, Roehrs TA. At the intersection of sleep deficiency and opioid use: mechanisms and therapeutic opportunities. Transl Res 2021;234:58-73. [PMID: 33711513 DOI: 10.1016/j.trsl.2021.03.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 O'Brien CB, Locklear CE, Glovak ZT, Zebadúa Unzaga D, Baghdoyan HA, Lydic R. Opioids cause dissociated states of consciousness in C57BL/6J mice. J Neurophysiol 2021;126:1265-75. [PMID: 34469699 DOI: 10.1152/jn.00266.2021] [Reference Citation Analysis]
16 Beydoun MA, Ng AE, Fanelli-Kuczmarski MT, Hossain S, Beydoun HA, Evans MK, Zonderman AB. Vitamin D status and its longitudinal association with changes in patterns of sleep among middle-aged urban adults. J Affect Disord 2021;282:858-68. [PMID: 33601729 DOI: 10.1016/j.jad.2020.12.145] [Reference Citation Analysis]
17 Sotelo MI, Tyan J, Dzera J, Eban-rothschild A. Sleep and motivated behaviors, from physiology to pathology. Current Opinion in Physiology 2020;15:159-66. [DOI: 10.1016/j.cophys.2020.01.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
18 Tanda G, Hersey M, Hempel B, Xi ZX, Newman AH. Modafinil and its structural analogs as atypical dopamine uptake inhibitors and potential medications for psychostimulant use disorder. Curr Opin Pharmacol 2021;56:13-21. [PMID: 32927246 DOI: 10.1016/j.coph.2020.07.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
19 Hersey M, Bacon AK, Bailey LG, Coggiano MA, Newman AH, Leggio L, Tanda G. Psychostimulant Use Disorder, an Unmet Therapeutic Goal: Can Modafinil Narrow the Gap? Front Neurosci 2021;15:656475. [PMID: 34121988 DOI: 10.3389/fnins.2021.656475] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Fragale JE, James MH, Avila JA, Spaeth AM, Aurora RN, Langleben D, Aston-Jones G. The Insomnia-Addiction Positive Feedback Loop: Role of the Orexin System. Front Neurol Neurosci 2021;45:117-27. [PMID: 34052815 DOI: 10.1159/000514965] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Gu Y, Sainburg LE, Kuang S, Han F, Williams JW, Liu Y, Zhang N, Zhang X, Leopold DA, Liu X. Brain Activity Fluctuations Propagate as Waves Traversing the Cortical Hierarchy. Cereb Cortex 2021;31:3986-4005. [PMID: 33822908 DOI: 10.1093/cercor/bhab064] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Li M, Cui J, Xu B, Wei Y, Fu C, Lv X, Xiong L, Qin D. Sleep Disturbances and Depression Are Co-morbid Conditions: Insights From Animal Models, Especially Non-human Primate Model. Front Psychiatry 2022;12:827541. [DOI: 10.3389/fpsyt.2021.827541] [Reference Citation Analysis]
23 Jones MR, Brandner AJ, Vendruscolo LF, Vendruscolo JCM, Koob GF, Schmeichel BE. Effects of Alcohol Withdrawal on Sleep Macroarchitecture and Microarchitecture in Female and Male Rats. Front Neurosci 2022;16:838486. [PMID: 35757544 DOI: 10.3389/fnins.2022.838486] [Reference Citation Analysis]
24 Zammit G, Krystal A. Evaluating lemborexant for the treatment of insomnia. Expert Opin Pharmacother 2021;22:1235-43. [PMID: 33711243 DOI: 10.1080/14656566.2021.1902987] [Reference Citation Analysis]
25 Martin CE, Dzierzewski JM, Keyser-Marcus L, Donovan EK, Ramey T, Svikis DS, Moeller FG. Sex Specific Sleep Parameters Among People With Substance Use Disorder. Front Psychiatry 2022;13:905332. [PMID: 35722562 DOI: 10.3389/fpsyt.2022.905332] [Reference Citation Analysis]
26 Ravichandran S, Bhatt RR, Pandit B, Osadchiy V, Alaverdyan A, Vora P, Stains J, Naliboff B, Mayer EA, Gupta A. Alterations in reward network functional connectivity are associated with increased food addiction in obese individuals. Sci Rep 2021;11:3386. [PMID: 33564081 DOI: 10.1038/s41598-021-83116-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
27 Roehrs T, Sibai M, Roth T. Sleep and alertness disturbance and substance use disorders: A bi-directional relation. Pharmacol Biochem Behav 2021;203:173153. [PMID: 33582097 DOI: 10.1016/j.pbb.2021.173153] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
28 Dokkedal-Silva V, Fernandes GL, Morelhão PK, Pires GN, Rowlett JK, Galduróz JCF, Berro LF, Tufik S, Andersen ML. Sleep, psychiatric and socioeconomic factors associated with substance use in a large population sample: A cross-sectional study. Pharmacol Biochem Behav 2021;210:173274. [PMID: 34547353 DOI: 10.1016/j.pbb.2021.173274] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Zlebnik NE, Holtz NA, Lepak VC, Saykao AT, Zhang Y, Carroll ME. Age-specific treatment effects of orexin/hypocretin-receptor antagonism on methamphetamine-seeking behavior. Drug Alcohol Depend 2021;224:108719. [PMID: 33940327 DOI: 10.1016/j.drugalcdep.2021.108719] [Reference Citation Analysis]
30 Yen CF, Lin HC, Ko CH, Wu HC, Hsu CY, Wang PW. Sleep quality among individuals with ketamine use and the mediating role of craving. Sci Rep 2020;10:20535. [PMID: 33239629 DOI: 10.1038/s41598-020-77631-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Vujanovic AA, Kauffman BY, Zegel M, Zvolensky MJ. COVID-related stress and substance use: examining the role of sleep disturbance. Cogn Behav Ther 2022;:1-17. [PMID: 35762877 DOI: 10.1080/16506073.2022.2079557] [Reference Citation Analysis]
32 Neisewander JL. Sleep Deprivation Dysregulates Brain Reward Circuitry: Implications for Psychiatric Disorders. Biol Psychiatry 2020;87:938-9. [PMID: 32446315 DOI: 10.1016/j.biopsych.2020.03.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]